We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
30 Jan 2023 - 02 Feb 2023

PET/MRI Machine Learning Model Eliminates Sentinel Lymph Node Biopsy in Most Breast Cancer Patients

By MedImaging International staff writers
Posted on 21 Nov 2022
Print article
Image: Graphical abstract (Photo courtesy of University Hospital Düsseldorf)
Image: Graphical abstract (Photo courtesy of University Hospital Düsseldorf)

The presence of lymph node metastases in breast cancer patients plays a crucial role in treatment planning, especially regarding the extent of surgery and radiation. Therefore, it is of high clinical relevance to distinguish patients with lymph node metastases from patients without lymph node metastases. Now, nearly 70% of breast cancer patients could find out if their cancer has spread to their lymph nodes without having to undergo an invasive sentinel node biopsy. New research shows that with the help of machine learning (a type of artificial intelligence), axillary lymph node metastasis can be reliably ruled out based on imaging with PET/MRI.

In the study, researchers at the Institute for Diagnostic and Interventional Radiology at the University Hospital Düsseldorf (Düsseldorf, Germany) sought to determine whether machine learning prediction models could determine lymph node status in PET/MRI examinations as accurately as an experienced radiologist could. A total of 303 primary breast cancer patients from three medical centers were recruited for the study and were divided into a training group sample and a testing group sample.

All patients underwent MRI and dedicated whole-body 18F-FDG PET/MRI. The imaging datasets were evaluated for axillary lymph node metastases based on structural and functional features. Machine learning models were developed based on the MRI and PET/MRI training group sample and were then applied to the testing group sample. The diagnostic accuracy of MRI was 87.5% for both radiologists and the machine learning algorithm. For PET/MRI, the accuracy was 89.3% for radiologists and 91.2% for machine learning. After adjusting the machine learning model for PET/MRI, a sensitivity of 96.2% and a specificity of 68.2% was achieved.

“Sixty percent of patients do not have lymph node metastases at initial diagnosis of breast cancer,” said study author Janna Morawitz, MD, radiology resident at the Institute for Diagnostic and Interventional Radiology at the University Hospital Düsseldorf. “As such, it would be desirable to be able to prove negative lymph node status by imaging with a high degree of certainty to spare these patients the invasive procedure of biopsy or surgery.”

Related Links:
University Hospital Düsseldorf 

Gold Supplier
SBRT Phantom with Removable Spine
E2E SBRT Phantom with Removable Spine Model 036S-CVXX-xx
New
Dynamic Flat Panel Detector
560RF
New
Protection Barrier
Ceiling Mounted Protection Shield
New
Ultrasound System
Xario 200G

Print article
CIRS -  MIRION

Channels

Ultrasound

view channel
Image: A combination of ultrasound and nanobubbles allows cancerous tumors to be destroyed without surgery (Photo courtesy of Tel Aviv University)

Ultrasound Combined With Nanobubbles Enables Removal of Tumors Without Surgery

The prevalent method of cancer treatment is surgical removal of the tumor, in combination with complementary treatments such as chemotherapy and immunotherapy. Therapeutic ultrasound to destroy the cancerous... Read more

General/Advanced Imaging

view channel
Image: Ultra-high-resolution photon-counting CT reveals bronchiolectasis (Photo courtesy of Medical University of Vienna)

Photon-Counting CT Shows More Post-COVID-19 Lung Damage

Photon-counting detector (PCD) CT has emerged in the last decade as a promising imaging tool. It works by converting X-ray photons directly into an electrical signal. This avoids the intermediate step... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.